News

ESSA Pharma Announces Significant Cash Distribution to Shareholders

ESSA Pharma Announces Significant Cash Distribution to Shareholders

ESSA Pharma Inc. Approves $80 Million Distribution

ESSA Pharma Inc. (NASDAQ: EPIX) has made a significant announcement regarding a cash distribution to its shareholders. Following a recent decision by the Supreme Court, the company revealed plans for a total cash distribution of $80 million to its common shareholders. This distribution is a key part of the company's winding-down process.

Details of the Cash Distribution

The approved capital return means that shareholders will see approximately $1.91 per common share, which includes the cash payable upon the finalization of an ongoing acquisition deal. This distribution is pivotal as it comes just before a special shareholder meeting aimed at discussing a strategic transaction with XenoTherapeutics, Inc.

Timeline for Payment

Scheduled for payment on a set date, this distribution will go to shareholders who hold shares as of the specified record date. These concrete steps highlight the determination of ESSA Pharma to manage its capital effectively, maintaining shareholder value amid changes in business operations.

Transaction with XenoTherapeutics

As part of broader strategic initiatives, the company is engaged in a transformative transaction with XenoTherapeutics, a non-profit that is set to acquire all outstanding common shares of ESSA. This move is expected to further reshape the company's future, allowing for new growth opportunities.

About ESSA Pharma Inc.

ESSA Pharma, a pharmaceutical entity, has been dedicated to developing innovative treatments for prostate cancer. With a focus on proprietary therapies, ESSA aims to address unmet medical needs within oncology. The strategic initiatives underscore the company's commitment to its mission while adapting to new market environments.

Contact Information for Shareholders

David Wood, the Chief Financial Officer, is available for inquiries from shareholders regarding this recent announcement. He can be reached at 778-331-0962 for any questions or clarifications regarding the distribution process or upcoming shareholder meeting.

Frequently Asked Questions

What is the amount of the cash distribution announced by ESSA Pharma?

The company has announced a cash distribution totaling $80 million to shareholders.

When will the distribution be paid to shareholders?

The cash distribution is scheduled to be paid on a specific date to shareholders of record.

What is the purpose of the cash distribution?

This distribution is part of the company's plan for winding down operations while ensuring shareholder value.

How much will each shareholder receive in this distribution?

Each shareholder is expected to receive approximately $1.91 per common share based on this distribution.

What transaction is ESSA Pharma currently involved in?

ESSA is undergoing a strategic transaction with XenoTherapeutics for the acquisition of all outstanding common shares as part of their future plans.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 1

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Syra Health Joins CMS ACCESS Model for Scalable Growth

Updated Category News Views 2

Syra Health Secures Spot in CMS ACCESS Model Every once in a while, a company gets a nod that could redefine its trajectory, and today it’s Syra Health’s turn at bat. Teaming up with HealthSync, they’ve clinched a position in the coveted CMS ACCESS model—a move not just about snagging headlines but potentially securing a golden ticket to a robust revenue stream...

Continue Reading
Flotek Faces Lawsuit: Investors Urged to Act Fast

Updated Category News Views 3

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Continue Reading
TPx Pivots Post-Bankruptcy, Rebuilding for New Growth

Updated Category News Views 15

TPx Rebounds with Stronger Foundation Folks, TPx just got itself a fresh pair of legs to stand on. Emerging from the labyrinth of Chapter 11 bankruptcy, TPx has managed to shave off a cumbersome load of debt and cement a pathway to long-term success. A court nod from the U.S. Bankruptcy Court for the Southern District of Texas confirmed their reorganization plan. It's a...

Continue Reading
Nanochon Tests Innovative Knee Implant in Human Trial

Updated Category News Views 2

Mending Knees with New Tech: The Chondrograft™ Debut Picture this: Nanochon's Chondrograft™ just hit the ground running. They've got a bite out of the future by diving headfirst into their First-in-Human (FIH) clinical study. This ain't your grandma's knee replacement talk. This is about changing the game for those knee cartilages that let out a groan every time you...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 2

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 1

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
Sports CIOs Tackle Venue Tech Ownership Challenges

Updated Category News Views 1

Untangling the Mess Behind Game Day Ever wonder why getting to your seat at a sports event feels seamless? It's like magic with your ticket appearing as a barcode on your phone, the concession stand knowing your order from last week's game, and sponsor ads personalized just for you. This is no easy feat. Behind the scenes, though, it's akin to a game of Twister. The...

Continue Reading
Ares Management Heads to Barclays Conference Spotlight

Updated Category News Views 3

All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 2

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading

Top 5 Most Recently Viewed Articles

AEye's Upcoming Q4 2024 Financial Results Conference Details

Updated Category News Views 170

AEye to Announce Financial Results for Q4 2024 AEye, Inc. (Nasdaq: LIDR), a pioneer in adaptive high-performance lidar solutions, has exciting developments as it prepares to share its financial performance for the fourth quarter of 2024. This pivotal report will be released after the market closes one day in February, signaling significant advancements and progress for...

Continue Reading
Empowering Wealth Creation Through Community Engagement Events

Updated Category News Views 215

Empowering Local Communities to Build Wealth In a powerful initiative to foster financial independence, community leaders are coming together to organize a significant event aimed at helping families create lasting wealth. Featuring prominent figures such as LA County Supervisor Holly J. Mitchell, this gathering is set to take place at the People's Independent Church of...

Continue Reading
Royalty Pharma Announces Quarterly Dividend for Shareholders

Updated Category News Views 196

Royalty Pharma Announces Dividend for Shareholders The board of directors at Royalty Pharma plc (Nasdaq: RPRX) has announced an exciting update regarding the company's commitment to its shareholders. The approved dividend for the second quarter of 2025 is set at $0.22 per Class A ordinary share, marking a crucial step in their ongoing dedication to rewarding investors....

Continue Reading
Nika Pharmaceuticals: Advancements in Pharma Production for 2026

Updated Category News Views 257

Recent Developments at Nika Pharmaceuticals, Inc. Nika Pharmaceuticals, Inc. (OTCQB: NIKA) has been making significant strides recently, as highlighted by CEO Dimitar Savov during a recent podcast appearance. In this episode, Savov detailed the company's achievements thus far and laid out the plans that will shape 2026—a pivotal year for Nika and its stakeholders....

Continue Reading
Mary Beth Kingston Joins Kontakt.io's Advisory Board to Innovate

Updated Category News Views 135

Mary Beth Kingston's Impact on Healthcare Technology Kontakt.io, a leader in healthcare Real-Time Location Systems (RTLS) and digital transformation, has welcomed Mary Beth Kingston to its Healthcare Advisory Board. With a remarkable career spanning over 40 years, Kingston is a notable advocate for nurse safety and wellbeing. Her expertise will be instrumental in...

Continue Reading